United States · FDA National Drug Code directory
VALGANCICLOVIR HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-753_3d5cd566-06ab-4e83-aba8-f692ff8a23dd
- Product NDC
- 65862-753
- Form
- TABLET
- Composition / generic term
- VALGANCICLOVIR HYDROCHLORIDE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160331
- Source listing expiry
- 20271231
Source-listed ingredients
- VALGANCICLOVIR HYDROCHLORIDE — 450 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (65862-753-01) · 65862-753-01
- 500 TABLET in 1 BOTTLE (65862-753-05) · 65862-753-05
- 180 TABLET in 1 BOTTLE (65862-753-18) · 65862-753-18
- 60 TABLET in 1 BOTTLE (65862-753-60) · 65862-753-60
- 1000 TABLET in 1 BOTTLE (65862-753-99) · 65862-753-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →